MedTrace Logo

Optimising Secondary Prevention and Quality of Life in Early Cardiac Rehabilitation

NCT04781699 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 498

Last updated 2021-11-08

No results posted yet for this study

Summary

The primary aim of this research is to explore the adherence and drop-out from early cardiac rehabilitation (CR), to inform interventions to support patient's adherence to CR and facilitate maintenance. The secondary aim is to understand which aspects of CR are essential for improving health-related quality of life in the short and long-term. This research will comprise four stages adopting a mixed-methods, quasi-experimental, repeated measures design.

Conditions

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • Sheffield Teaching Hospitals NHS Foundation Trust

    collaborator OTHER

  • Royal Brompton & Harefield NHS Foundation Trust

    collaborator OTHER

  • Northumbria Healthcare NHS Foundation Trust

    collaborator OTHER

  • NHS Ayrshire and Arran

    collaborator OTHER

  • Belfast Health and Social Care Trust

    collaborator OTHER

  • Aneurin Bevan University Health Board

    collaborator OTHER

  • Sheffield Hallam University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-19
Primary Completion
2022-04-01
Completion
2022-09-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04781699 on ClinicalTrials.gov